Company
United StatesPublic company, NASDAQ: VCELVericel Corporation (NASDAQ: VCEL), Burlington, MA – FDA Inspections
Inspection records and compliance data for Vericel Corporation in Burlington, MA. 1 FDA inspection on record, 1 Form 483, last inspected February 06, 2026. Publicly traded as NASDAQ: VCEL.
Company Profile
This profile covers Vericel Corporation based in Burlington, MA, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
Inspected February 6, 2026.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| February 6, 2026 | Not classified | Biologics | 1304694 |
FDA documents
Form 483s (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Vericel Corporation
Stock ticker
VCEL
Exchange
NASDAQ
Share price
$57.42
Market cap
$2.9B
Price as of
November 13, 2026
FEI Number
3038730492
Address
25 Blue Sky Dr, Burlington, MA 01803-2770, United States
Country
United States
ID: 5ad02c4b-4736-47d1-b55a-44beb892c7c0